Abstract
Salubrinal is a specific eIF2α phosphatase inhibitor that inhibits ER stress-mediated apoptosis. However, maintaining hyper-phosphorylated eIF2α state with high doses of salubrinal treatment promotes apoptosis in some cancer cells. In this report, we found that salubrinal induced apoptosis of EBV-transformed B cells. Notably, salubrinal induced ROS generation and p38 MPAK activation, which then induced expression of FasL. Moreover, salubrinal subsequently led to activation of caspases, calcium redistribution, Bax translocation, cytochrome c release, and apoptosis. These findings suggest that salubrinal may be a novel therapeutic approach for EBV-associated malignant diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 235-248 |
| Number of pages | 14 |
| Journal | Cancer letters |
| Volume | 313 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2011 Dec 27 |
| Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by the SRC/ERC Program of MOST/KOSEF (Grant #: R11-2005-017) and the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (Grant #: 0920040).
Keywords
- Apoptosis
- B cell
- Bax
- Calcium
- EBV
- P38 MAPK
- ROS
- Salubrinal
ASJC Scopus subject areas
- Oncology
- Cancer Research